Биология ва тиббиёт муаммолари 2025, №2.1 (160)

Subject of the article

РОЛЬ КИШЕЧНОГО МИКРОБИОМА В РЕГУЛЯЦИИ МЕТАБОЛИЗМА И ГОРМОНАЛЬНОГО БАЛАНСА ПРИ МЕНОПАУЗЕ (153-157)

Authors

Бакоева Нилуфар Матекуб кизи, Назарова Нозимахон Суннатилла кизи, Тен Инна Игоревна

Institution

Республиканский специализированный научно-практический медицинский центр эндокринологии имени акад. Ё.Х. Туракулова, Республика Узбекистан, г. Ташкент

Abstract

За последние годы исследования кишечного микробиома значительно продвинулись, демонстрируя его влияние на метаболические, иммунные, нервные и эндокринные процессы в организме. Современная наука рассматривает кишечный микробиом как ключевого регулятора здоровья, а изучение его состава и функций открывает новые возможности для медицины. Несмотря на влияние неизменных факторов (генетики и возраста), микробиом подвержен изменениям под воздействием образа жизни: питания, физической активности, уровня стресса и качества сна. Это делает его потенциальной мишенью для терапевтических вмешательств. Таким образом, кишечный микро-биом становится важным направлением современной медицины, открывая новые пути к улучшению здоровья и профилактике заболеваний.

Key words

кишечная микробиота, менопауза, ожирение, эстрогены, менопаузальная гормональная терапия.

Literature

1.Van de Wiele T, Vanhaecke L, Boeckaert C, Peru K, Headley J, Verstraete W, et al. Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ Health Perspect. 2005;113(1):6–10. https://doi.org/10.1289/ehp.7259. 2.Hogan AM, Collins D, Baird AW, Winter DC. Estrogen and its role in gastrointestinal health and disease. Int J Colo- rectal Dis. 2009;24(12):1367–75. https://doi.org/10.1007/ s00384-009-0785-0. 3.Waclawiková B, Codutti A, Alim K, El Aidy S. Gut microbiota- motility interregulation: insights from in vivo, ex vivo and in silico studies. Gut Microbes. 2022;14(1):1997296. https://doi. org/10.1080/19490976.2021.1997296. 4.So SY, Savidge TC. Sex-Bias in Irritable Bowel Syn-drome: Linking Steroids to the Gut-Brain Axis. Front Endocrinol. 2021;12:684096. https://doi.org/10.3389/fendo.2021.684096. 5.So SY, Savidge TC. Gut feelings: the microbiota-gut-brain axis on steroids. Am J Physiol Gastrointest Liver Physiol. 2022;322(1):G1–20. https://doi.org/10.1152/ajpgi.00294.2021. 6.Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Ad-ams J, et al. Sex steroid deficiency-associated bone loss is microbiota depend- ent and prevented by probiotics. J Clin Invest. 2016;126(6):2049– 63. https://doi.org/10.1172/JCI86062. 7.Shieh A, Epeldegui M, Karlamangla AS, Greendale GA. Gut permeability, inflammation, and bone density across the meno- pause transition. JCI Insight. 2020;5(2). https://doi.org/10.1172/ jci.insight.134092. 8.Salazar AM, Aparicio R, Clark RI, Rera M, Walker DW. Intes- tinal barrier dysfunction: an evolutionarily con-served hallmark of aging. Dis Model Mech. 2023;16(4):dmm049969. https://doi. org/10.1242/dmm.049969. 9.J. H. Shin, Y. H. Park, M. Sim, S. A. Kim, H. Joung, and D. M. Shin, “Serum level of sex steroid hormone is associ-ated with diversity and profiles of human gut microbiome,” Research in Microbiology, vol. 170, no. 4-5, pp. 192–201, 2019. 10.J. A. Santos-Marcos, O. A. Rangel-Zuñiga, R. Jimenez-Lucena et al., “Influence of gender and menopausal status on gut microbiota,” Maturitas, vol. 116, pp. 43–53, 2018. 11.J. Zhu, M. Liao, Z. Yao et al., “Breast cancer in post-menopausal women is associated with an altered gut metagenome,” Microbiome, vol. 6, no. 1, p. 136, 2018. 12.K. Sjögren, C. Engdahl, P. Henning et al., “The gut microbiota regulates bone mass in mice,” Journal of Bone and Mineral Research: the Official Journal of the Ameri-can Society for Bone and Mineral Research, vol. 27, no. 6, pp. 1357–1367, 2012. 13.S. O. Fetissov and P. Déchelotte, “The new link between gutbrain axis and neuropsychiatric disorders,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 5, pp. 477–482, 2011. 14.T. Meštrović, M. Matijašić, M. Perić, H. Čipčić Paljetak, A. Barešić, and D. Verbanac, “The role of gut, vaginal, and urinary microbiome in urinary tract infections: from bench to bedside,” Diagnostics (Basel, Switzerland), vol. 11, no. 1, 2021. 15.Kwa M, Plottel CS, Blaser MJ and Adams S (2017) The intestinal microbiome and estrogen receptor-positive fe-male breast cancer. J Natl Cancer Inst 38, 173–188. 16.Mauvais-Jarvis F, Manson JE, Stevenson JC and Fon-seca VA (2017) Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications. Endocr Rev 38, 173–188. 17.Chao PY, Chiang TI, Chang IC, Tsai FL, Lee HH, Hsieh K, Chiu YW, Lai TJ, Liu JY, Hsu LS et al. (2017) Amelioration of estrogen-deficiency-induced Gut microbiota features in pre- and post-menopausal women H. Zhao et al. obesity by Ocimum gratissimum. Int J Med Sci 14, 896–901. 18.Zhang X,Zhang D, Jia H, Feng Q, Wang D, Liang D, Wu X, Li J, Tang L et al. (2015) The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21, 895–905. 19.Wen C, Zheng Z, Shao T, Liu L, Xie Z, Le Chatelier E, He Z, Zhong W, Fan Yet al. (2017) Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis. Genome Biol 18, 142. 20.Takimoto T, Hatanaka M, Hoshino T, Takara T, Tanaka K, Shimizu A, Morita H and Nakamura T (2018) Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: a randomized, placebo-controlled, double- blind clinical trial. Biosci Microbiota Food Health 37, 87–96. 21.Baker JM, Al-Nakkash L and Herbst-Kralovetz MM (2017) Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas 103, 45–53. 22.Sharma N, Sharma RK, Tewari S, Chauhan M and Bhatia A (2018) Association of periodontal inflammation, systemic inflammation, and duration of menopausal years in postmenopausal women. Quintessence Int 49, 123–131. 23. Brusselaers N, Maret-Ouda J, Konings P, El-Serag HB and Lagergren J (2017) Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int JCancer 140, 1693–1699. 24. Ortega-Vega EL, Guzma´ n-Castan˜ eda SJ, Campo O, Vela´ squez-Mejı´a EP, de la Cuesta-Zuluaga J, Bedoya G and Escobar JS (2019) Variants in genes of innate immunity, appetite control and energy metabolism are associated with host cardiometabolic health and gut microbiota composition. 25. Russell JE, Morimoto S, Birge SJ, Fausto A and Avioli LV (1986) Effects of age and estrogen on calcium absorp-tion in the rat. J Bone Miner Res 1, 185–189. 26.Pereira FC and Berry D (2017) Microbial nutrient nich-es in the gut. Environ Microbiol 19, 1366–1378. 27.Vogt SL, Pena-Diaz J and Finlay BB (2015) Chemical communication in the gut: Effects of microbiota- generated metabolites on gastrointestinal bacterial pathogens. Anaerobe 34, 106–115. 28.Kaliannan K, Robertson RC, Murphy K, Stanton C, Kang C, Wang B, et al. Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syn-drome in mice. Microbiome. 2018;6(1):205. 29.Jackova Z, Stepan JJ, Coufal S, Kostovcik M, Galanova N, Reiss Z, et al. Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospec- tive study. Front Endocrinol. 2023;14:1139056. 30.Mayneris-Perxachs J, Arnoriaga-Rodriguez M, Luque-Cordoba D, Priego-Capote F, Perez-Brocal V, Moya A, et al. Gut micro- biota steroid sexual dimorphism and its im-pact on gonadal ster- oids: influences of obesity and menopausal status. Microbiome. 2020;8(1):136. 31.Leite G, Barlow G, Parodi G, Pimentel M, Chang C, Hosseini A, et al. Duodenal microbiome changes in post-menopausal women: effects of hormone therapy and implications for cardiovascular risk. Menopause. 2022;29(3):264–75. 32.Kawano N, Koji T, Hishikawa Y, Murase K, Murata I, Kohno S. Identification and localization of estrogen recep-tor alpha- and beta-positive cells in adult male and female mouse intestine at various estrogen levels. Histochem Cell Biol. 2004;121(5):399– 405. 33.Tan TG, Sefik E, Geva-Zatorsky N, Kua L, Naskar D, Teng F, et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci U S A. 2016;113(50):E8141–50. 34.Yu M, Malik Tyagi A, Li JY, Adams J, Denning TL, Weitzmann MN, et al. PTH induces bone loss via microbi-al-dependent expan- sion of intestinal TNF(+) T cells and Th17 cells. Nat Commun. 2020;11(1):468.